Hide filtersShow filters × Close Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on Valneva’s EUR 61.2m Follow-On Offering Bryan, Garnier & Co. acts as Sole Secondary Advisor to a group of historical shareholders in Algolia on the secondary sale of their shares to Noteus Partners, Karmel Capital and Revaia Bryan, Garnier & Co acts as Sole Financial Advisor to CENIT on their majority acquisition of Analysis Prime Bryan, Garnier & Co acts as Sole Financial Advisor to Francisco Partners on its investment in Orisha, a leading European Vertical Market Software platform Bryan, Garnier & Co acts as Sole Global Coordinator & Sole Bookrunner on Nicox’s Euronext Paris EUR 3.3m Rights Issue Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on Cinclus Pharma’s SEK 715m Nasdaq Stockholm IPO Bryan, Garnier & Co acts as Sole Financial Advisor to Strohm and its shareholders in the context of the company’s EUR 30m fundraise led by Senco Hydrogen Capital Bryan, Garnier & Co acts as Sole Financial Advisor to German medical device CRO/CDMO seleon GmbH Bryan, Garnier & Co acts as Financial Advisor to Monese and XYB on each securing new funding and becoming two independent entities Bryan, Garnier & Co acts as Sole Debt Advisor to Claranova on their new EUR 108 million loan financing Bryan, Garnier & Co acts as Sole Financial Advisor to Health+Commerce, an integrated healthcare marketing agency, on its sale to Supreme Group Bryan, Garnier & Co acts as Sole Global Coordinator & Joint Bookrunner on ONWARD Medical’s EUR 20 million Follow-On Offering
